Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Gynaecology highlights from ASCO 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.07.18
Views: 359
Rating:

Prof Christina Fotopoulou - Imperial College London Healthcare Trust, London, UK

Prof Fotopolou speaks with ecancer at BCGS 2018 about recent headlines in treatment of ovarian cancer.

She highlights the results of the GOG0213 study presented Dr Coleman which contradicted the earlier DESKTOPIII study, and Prof Fotopolou explores differences in patient cohort and staging.

She also discusses the suitability of adjuvant chemotherapy for advanced ovarian cancer based on results from a Japanese study, which failed to show noninferiority of debulking treatments for some patients

Prof Fotopoulou spoke with ecancer about the role of minimally invasive surgery for ovarian cancer here.

Read about the GOG0213 study here.
Read about the DESKTOP III study here.

Related videos

follow us

NCRI 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation